SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-23-081572
Filing Date
2023-10-30
Accepted
2023-10-30 16:59:52
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea187455-f1_scinai.htm F-1 354921
2 ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD ea187455ex3-1_scinai.htm EX-3.1 307314
3 OPINION OF GOLDFARB GROSS SELIGMAN & CO., ISRAELI COUNSEL TO THE COMPANY, REGARD ea187455ex5-1_scinai.htm EX-5.1 8792
4 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ea187455ex23-1_scinai.htm EX-23.1 2555
5 FILING FEE TABLE ea187455ex-fee_scinai.htm EX-FILING FEES 23619
6 GRAPHIC image_001.jpg GRAPHIC 16430
7 GRAPHIC ex5-1_001.jpg GRAPHIC 11339
8 GRAPHIC ex5-1_002.jpg GRAPHIC 32526
  Complete submission text file 0001213900-23-081572.txt   781828
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-275217 | Film No.: 231361144
SIC: 2836 Biological Products, (No Diagnostic Substances)